WASHINGTON (Reuters) – As early as 2000, U.S. health authorities raised concerns about the French breast implant maker at the heart of a scandal affecting hundreds of thousands of women worldwide. That was almost ten years before the company came under scrutiny from European regulators. The Food and Drug Administration sent an investigator to inspect a plant run by the manufacturer, Poly Implant Prothese (PIP), at La Seyne Sur Mer in southeastern France in May 2000. …

Quoted from Insight: FDA warned PIP on implant safety in 2000 on Yahoo! News – Latest News & Headlines

Leave a Reply


This site uses Akismet to reduce spam. Learn how your comment data is processed.